Caley Castelein's Insider Trades & SAST Disclosures

Caley Castelein's most recent trade in Whitehawk Therapeutics Inc. was a trade of 1,666,000 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on March 4, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Whitehawk Therapeutics Inc.
Caley Castelein Director Grant, award, or other acquisition of securities at price $ 2.40 per share. 04 Mar 2025 1,666,000 2,165,998 - 2.4 3,998,400 Common Stock
Whitehawk Therapeutics Inc.
Caley Castelein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 45,832 45,832 - - Stock Option (right to buy)
Tourmaline Bio Inc
Caley Castelein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,000 10,000 - - Stock Option (Right to Buy)
Whitehawk Therapeutics Inc.
Caley Castelein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 28,255 28,255 - - Stock Option (right to buy)
Whitehawk Therapeutics Inc.
Caley Castelein Director Grant, award, or other acquisition of securities at price $ 12.50 per share. 26 Sep 2022 240,000 499,998 - 12.5 3,000,000 Common Stock
Whitehawk Therapeutics Inc.
Caley Castelein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 18,573 18,573 - - Stock Option (right to buy)
Whitehawk Therapeutics Inc.
Caley Castelein Director Purchase of securities on an exchange or from another person at price $ 13.08 per share. 26 Aug 2021 259,998 259,998 - 13.1 3,399,994 Common Stock
Whitehawk Therapeutics Inc.
Caley Castelein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 17,549 17,549 - - Stock option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades